Latest News of CRSP
CRISPR Therapeutics (NasdaqGM:CRSP) Sees 12% Weekly Dip Following COO Resignation
By Yahoo! Finance | 2 days ago
CRISPR Therapeutics AG (CRSP): the Most Oversold Pharma Stock to Buy According to Analysts
By Yahoo! Finance | 1 month ago
CRISPR (CRSP) Upgraded to Outperform by Evercore, Price Target Raised to $99
By Yahoo! Finance | 1 month ago
CRISPR Therapeutics AG (CRSP): Among Cathie Wood's Top Stock Picks for 2025
By Yahoo! Finance | 2 months ago